Driving under the influence of cannabis: Pitfalls, validation, and quality control of a UPLC-MS/MS method for the quantification of tetrahydrocannabinol in oral fluid collected with statsure, quantisal, or certus collector

Therapeutic Drug Monitoring

Volumn 35, Issue 1, 2013, Pages 101-111

  Wille, Sarah M R ^a   Di Fazio, Vincent ^a   Ramírez Fernandez, Maria Del Mar ^a   Kummer, Natalie ^a   Samyn, Nele ^a  

^a National Institute of Criminalistics and Criminology   (Belgium)

Author keywords

DUID; legislation; roadside on site testing; saliva; THC

Indexed keywords

HEXANE; TETRAHYDROCANNABINOL;

ADSORPTION; ANALYTICAL EQUIPMENT; ARTICLE; CAR DRIVING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRIVING UNDER THE INFLUENCE OF DRUG; DRUG DEPENDENCE; INTERMETHOD COMPARISON; ORAL FLUID COLLECTION DEVICE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ROOM TEMPERATURE; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS;

AUTOMOBILE DRIVING; BODY FLUIDS; CANNABIS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SALIVA; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY; TETRAHYDROCANNABINOL;

EID: 84872855833     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e318278dbe4     Document Type: Article

References (37)

1. World Health Organization. World report on road traffic injury prevention [WHO website] 2004. Available at: http://www.who.int/violence-injury- prevention/publications/road-traffic/world-report/en. Accessed January 13, 2012.
2. Parliament of Belgium. Wet tot invoering van speekseltesten op drugs in het verkeer, 31 juli 2009, Belgisch Staatsblad (Moniteur Belge). Parliament of France.
3. Relative à la conduite sous l'influence de substances ou plantes classes comme stupéfiants, 3 février, Loin 8. 2003: 2003-2087.
4. Steinmeyer S, Ohr H, Maurer HJ, et al. Practical aspects of roadside tests for administrative traffic offences in Germany. Forensic Sci Int. 2001; 121:33-36.
5. Ceder G. Drugged driving in Sweden-effects of new legislation concerning zero-tolerance for narcotic drugs. In: Laurell H, ed. Proceedings of the 15th International Conference of Alcohol, Drugs and Traffic Safety (ICADTS) [book on CD-ROM T2000]. Stockholm, Sweden. Paper 509. Parliament of Victoria. Road Safety (Drug Driving) Act 111/2003. 2003.
6. Bosker WM, Huestis MA. Oral fluid testing for drugs of abuse. Clin Chem. 2009;55:1910-1931.
7. Samyn N, Laloup M, De Boeck G. Bioanalytical procedures for determination of drugs of abuse in oral fluid. Anal Bioanal Chem. 2007;388: 1437-1453.
8. Wille SMR, Ramírez-Fernandez M, Samyn N, et al. Conventional and alternative matrices for driving under the influence of cannabis: recent progress and remaining challenges. Anal Bioanal Chem. 2010;2:791-806.
9. Mortier KA, Clauwaert KM, Lambert WE, et al. Pitfalls associated with liquid chromatography/electrospray tandem mass spectrometry in quantitative bioanalysis of drugs of abuse in saliva. Rapid Commun Mass Spectrom. 2001;5:1773-1775.
10. Dams R, Huestis MA, Lambert WE, et al. Matrix effect in bioanalysis of illicit drugs with LC-MS/MS: influence of ionization type, sample preparation, and biofluid. J Am Soc Mass Spectrom. 2003;14:1290-1294.
11. Langel K, Engblom C, Pehrsson A, et al. Drug testing in oral fluid - evaluation of sample collection devices. J Anal Toxicol. 2008;32:393-401.
12. Badawi N, Simonsen KW, Steentoft A, et al. Simultaneous screening and quantification of 29 drugs of abuse in oral fluid by solid-phase extraction and ultraperformance LC-MS/MS. Clin Chem. 2009;55:2004-2018.
13. Simões SS, Ajenjo AC, Franco JM, et al. Liquid chromatography/ tandem mass spectrometry for the qualitative and quantitative analysis of illicit drugs and medicines in preserved oral fluid. Rapid Commun Mass Spectrom. 2009;23:1451-1460.
14. Sergi M, Bafile E, Compagnone D, et al. Multiclass analysis of illicit drugs in plasma and oral fluids by LC-MS/MS. Anal Bioanal Chem. 2009;393:709-718.
15. Langel K, Gunnar T, Ariniemi K, et al. A validated method for the detection and quantitation of 50 drugs of abuse and medicinal drugs in oral fluid by gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl. 1998;713:111-135.
16. Wang IT, Feng YT, Chen CY. Determination of 17 illicit drugs in oral fluid using isotope dilution ultra-high performance liquid chromatography/tandem mass spectrometry with three atmospheric pressure ionizations. J Chromatogr B Analyt Technol Biomed Live Sci. 2010;878: 3095-3105.
17. Elliott S, Woolacott H, Braithwaite R. The prevalence of drugs and alcohol found in road traffic fatalities: a comparative study of victims. Sci Justice. 2009;49:19-23.
18. Raes E, Van den Neste T, Verstraete AG. Drug Use, Impaired Driving and Traffic Accidents. No 8. Luxembourg, Luxembourg: EMCDDA Insights Series; 2008.
19. Raes E, Verstraete AG. Cannabis and driving: the situation in Europe. Ann Pharm Fr. 2006;64:197-203.
20. Isalberti C, Van der Linden T, Legrand S, et al. Prevalence of alcohol and other psychoactive substances in injured and killed drivers [deliverable 2.2.5. DRUID Web site], 2011. Available at: http://www.druid-project.eu/cln-031/ nn-107548/Druid/EN/deliveraleslist/downloads/Deliverable-2-2-5,templateId=raw, property=publicationFile.pdf/Deliverable-2-2-5.pdf. Accessed January 13, 2012.
21. Blencowe T, Pehrsson A, Lillsunde P, et al. Analytical evaluation of oral fluid screening devices and preceding selection procedures [deliverable 3.2.2. DRUID Web site], 2011. Available at: http://www.druid-project.eu/cln-031/nn- 107548/Druid/EN/deliveraleslist/downloads/Deliverable-3-2-2,templateId=raw, property=publicationFile.pdf/Deliverable-3-2-2.pdf. Accessed January 13, 2012.
22. Wille SMR, Peters FT, Di Fazio V, et al. Practical aspects concerning validation and quality control for forensic and clinical bioanalytical quantitative methods. Accred Qual Assur. 2011;16:279-292.
23. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine. Guidance for industry - bioanalytical method validation [FDA Web site], 2001. Available at: http://www.fda.gov/cder/guidance/index. htm. Accessed September 10, 2010.
24. Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency (EMEA). Guideline bioanalytical method validation [EMEAWeb site], 21 July, 2011. Available at: http://www.ema.europa.eu/ema/pages/includes/document/ open-document.jsp?webContentId=WC500109686. Accessed January 13, 2012.
25. Peters FT, Maurer HH. Bioanalytical method validation and its implications for forensic and clinical toxicology - a review. Accred Qual Assur. 2002;7:441-449.
26. Peters FT, Drummer OH, Musshoff F. Validation of new methods. Forensic Sci Int. 2007;165:216-224.
27. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem. 2003;75:3019-3030.
28. Ellison SLR, Williams A, eds. Use of Uncertainty Information in Compliance Assessment [EURACHEM/CITAC Guidelines]. 2007. Available at: http://www.eurachem.org/. Accessed January 25, 2011.
29. Moore C, Coulter C, Uges D, et al. Cannabinoids in oral fluid following passive exposure to marijuana smoke. Forensic Sci Int. 2011;212:227-230.
30. Walsh JM, Verstraete AG, Huestis MA, et al. Guidelines for research on drugged driving. Addiction. 2008;103:1258-1268.
31. Milman G, Barnes AJ, Lowe RH, et al. Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry. J Chromatogr A 2010;1217:1513-1521.
32. Toennes SW, Ramaekers JG, Theunissen EL, et al. Pharmacokinetic properties of Δ9-tetrahydrocannabinol in oral fluid of occasional and chronic users. J Anal Toxicol. 2010;34:216-221.
33. Lee D, Milman G, Schwope DM, et al. Cannabinoid stability in authentic oral fluid after controlled cannabis smoking. Clin Chem. 2012;58:1101-1109.
34. Westgard JO. Internal quality control: planning and implementation strategies. Ann Clin Biochem. 2003;40:593-611.
35. Westgard JO, Barry PL, Hunt MR. A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem. 1981;27:493-501.
36. Gjerde H, Normann PT, Christophersen AS. The prevalence of alcohol and drugs in sampled oral fluid is related to sample volume. J Anal Toxicol. 2010;7:416-419.
37. Wille SMR, Raes E, Lillsunde P, et al. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs. Ther Drug Monit. 2009;31:511-519.